Head to Head Analysis: Amplifon (OTCMKTS:AMFPF) versus Cosmos Health (NASDAQ:COSM)

Cosmos Health (NASDAQ:COSM – Get Free Report) and Amplifon (OTCMKTS:AMFPF – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Profitability

This table compares Cosmos Health and Amplifon’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cosmos Health -33.08% -56.88% -18.03%
Amplifon 3.01% 15.03% 4.29%

Institutional & Insider Ownership

12.6% of Cosmos Health shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Cosmos Health and Amplifon”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cosmos Health $65.27 million 0.52 -$19.15 million ($0.64) -0.52
Amplifon $2.71 billion 0.91 $103.33 million $0.37 30.30

Amplifon has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than Amplifon, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for Cosmos Health and Amplifon, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cosmos Health 1 0 0 0 1.00
Amplifon 0 2 3 0 2.60

Volatility & Risk

Cosmos Health has a beta of 4.69, suggesting that its stock price is 369% more volatile than the S&P 500. Comparatively, Amplifon has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500.

Summary

Amplifon beats Cosmos Health on 10 of the 13 factors compared between the two stocks.

About Cosmos Health

(Get Free Report)

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.